CMC Bottleneck is Choking Biopharma's Drug Pipeline, says Zifo

Summary

Zifo released a position paper arguing that Chemistry, Manufacturing, Controls (CMC) issues including fragmented data, poor scientific handoffs, and outdated technology transfer models are creating a billion-dollar bottleneck in the biopharma drug pipeline.